33.56
price up icon0.27%   0.09
after-market アフターアワーズ: 33.56
loading
前日終値:
$33.47
開ける:
$33.1
24時間の取引高:
1.12M
Relative Volume:
1.02
時価総額:
$2.00B
収益:
$66.05M
当期純損益:
$-422.60M
株価収益率:
-4.6283
EPS:
-7.251
ネットキャッシュフロー:
$-384.73M
1週間 パフォーマンス:
+4.00%
1か月 パフォーマンス:
-15.93%
6か月 パフォーマンス:
+20.03%
1年 パフォーマンス:
-8.51%
1日の値動き範囲:
Value
$32.48
$33.81
1週間の範囲:
Value
$31.71
$34.65
52週間の値動き範囲:
Value
$22.24
$46.00

Agios Pharmaceuticals Inc Stock (AGIO) Company Profile

Name
名前
Agios Pharmaceuticals Inc
Name
セクター
Healthcare (1080)
Name
電話
617-649-8600
Name
住所
88 SIDNEY STREET, CAMBRIDGE, MA
Name
職員
540
Name
Twitter
@AgiosPharma
Name
次回の収益日
2026-07-30
Name
最新のSEC提出書
Name
AGIO's Discussions on Twitter

Compare AGIO vs VRTX, REGN, ARGX, RVMD, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AGIO icon
AGIO
Agios Pharmaceuticals Inc
33.56 2.04B 66.05M -422.60M -384.73M -7.251
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
505.75 133.25B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
803.48 82.16B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
851.29 54.80B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
203.71 43.99B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
347.48 40.62B 5.76B 514.49M 1.10B 4.4813

Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-20 繰り返されました H.C. Wainwright Buy
2025-11-24 開始されました Truist Buy
2025-11-20 アップグレード Leerink Partners Market Perform → Outperform
2025-11-19 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-24 開始されました H.C. Wainwright Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-10-10 再開されました Raymond James Outperform
2024-09-27 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-08 開始されました Cantor Fitzgerald Overweight
2023-02-03 開始されました Piper Sandler Overweight
2022-11-17 アップグレード Goldman Sell → Neutral
2022-07-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-12-03 開始されました BofA Securities Buy
2021-07-30 ダウングレード Goldman Neutral → Sell
2021-07-01 開始されました Raymond James Mkt Perform
2021-06-10 開始されました H.C. Wainwright Buy
2021-03-01 ダウングレード JP Morgan Overweight → Neutral
2021-03-01 アップグレード SVB Leerink Mkt Perform → Outperform
2021-02-26 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-10-22 アップグレード Barclays Equal Weight → Overweight
2020-03-04 開始されました Barclays Equal Weight
2019-11-26 開始されました Cantor Fitzgerald Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-05-23 再開されました Goldman Neutral
2019-02-15 アップグレード SVB Leerink Mkt Perform → Outperform
2018-09-25 開始されました Leerink Partners Mkt Perform
2018-05-23 開始されました Citigroup Buy
2018-04-11 繰り返されました Credit Suisse Outperform
2018-02-15 繰り返されました Needham Buy
2018-02-15 繰り返されました SunTrust Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-08-10 繰り返されました Needham Buy
2017-08-08 繰り返されました SunTrust Buy
2017-08-02 アップグレード Leerink Partners Mkt Perform → Outperform
2017-06-26 ダウングレード Janney Buy → Neutral
2017-01-17 アップグレード Oppenheimer Perform → Outperform
2016-10-24 開始されました Needham Buy
2016-06-13 アップグレード JP Morgan Neutral → Overweight
2016-05-18 繰り返されました SunTrust Buy
すべてを表示

Agios Pharmaceuticals Inc (AGIO) 最新ニュース

pulisher
Aug 16, 2026

612,850 Shares in Agios Pharmaceuticals, Inc. $AGIO Acquired by SCS Capital Management LLC - MarketBeat

Aug 16, 2026
pulisher
Aug 15, 2026

Q4 2025 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

Aug 15, 2026
pulisher
Aug 13, 2026

Assenagon Asset Management S.A. Has $3.86 Million Stock Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Aug 13, 2026
pulisher
Aug 12, 2026

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO) - The Globe and Mail

Aug 12, 2026
pulisher
Aug 11, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Agios Pharmaceuticals, Inc. (AGIO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Aug 11, 2026
pulisher
Aug 11, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Aug 11, 2026
pulisher
Aug 11, 2026

Agios Pharmaceuticals (AGIO) Short Interest & Short Float | Updated Aug 2026 - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Agios Pharmaceuticals, Inc. (AGIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Aug 11, 2026
pulisher
Aug 10, 2026

Sei Investments Co. Acquires 49,198 Shares of Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Aug 10, 2026
pulisher
Aug 08, 2026

Responsive Playbooks and the AGIO Inflection - Stock Traders Daily

Aug 08, 2026
pulisher
Aug 08, 2026

FARALLON CAPITAL MANAGEMENT LLC Adds to Agios Pharmaceuticals In - GuruFocus

Aug 08, 2026
pulisher
Aug 08, 2026

Agios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds - Sahm

Aug 08, 2026
pulisher
Aug 07, 2026

AGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Agios Pharmaceuticals (NASDAQ:AGIO) Price Target Raised to $34.00 at JPMorgan Chase & Co. - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Agios Pharmaceuticals, Inc. (AGIO) And Encourages Investors to Connect - ACCESS Newswire

Aug 07, 2026
pulisher
Aug 07, 2026

Agios Pharmaceuticals (AGIO) Chief Medical Officer Sarah Gheuens Sells 30,000 Shares - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Agios Pharmaceuticals, Inc. (AGIO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Aug 07, 2026
pulisher
Aug 06, 2026

Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells 30,000 Shares - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Agios Pharmaceuticals (AGIO) CMO sells 30,000 shares in plan trade - Stock Titan

Aug 06, 2026
pulisher
Aug 06, 2026

How Surging Revenue With Ongoing Losses Will Impact Agios Pharmaceuticals (AGIO) Investors - simplywall.st

Aug 06, 2026
pulisher
Aug 04, 2026

AGIO (NASDAQ: AGIO) insider Sarah Gheuens files to sell 30,000 shares - stocktitan.net

Aug 04, 2026
pulisher
Aug 04, 2026

Dimensional Fund Advisors LP Increases Position in Agios Pharmaceuticals, Inc. $AGIO - marketbeat.com

Aug 04, 2026
pulisher
Aug 04, 2026

Agios Pharmaceuticals (AGIO) Stock Analysis: High Potential Upside In The Biotech Sector - DirectorsTalk Interviews

Aug 04, 2026
pulisher
Aug 03, 2026

Farallon Capital (AGIO) discloses 5.9M-share, 9.9% position in Agios - Stock Titan

Aug 03, 2026
pulisher
Aug 02, 2026

Seven Fleet Capital Management LP Has $7.09 Million Stock Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Aug 02, 2026
pulisher
Aug 02, 2026

Arrowstreet Capital Limited Partnership Makes New Investment in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Aug 02, 2026
pulisher
Aug 01, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Agios Pharmaceuticals, Inc. (AGIO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Aug 01, 2026
pulisher
Aug 01, 2026

Price to sales forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO - TradingView

Aug 01, 2026
pulisher
Jul 31, 2026

Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39 - Moomoo

Jul 31, 2026
pulisher
Jul 31, 2026

A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $39 to $55 - Moomoo

Jul 31, 2026
pulisher
Jul 31, 2026

Truist Financial Issues Pessimistic Forecast for Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price - MarketBeat

Jul 31, 2026
pulisher
Jul 30, 2026

AGIO: Q2 2026 delivered $44.7M revenue, strong AQVESME launch, and pipeline progress with ~$1B cash - TradingView

Jul 30, 2026
pulisher
Jul 30, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - PR Newswire

Jul 30, 2026
pulisher
Jul 30, 2026

Agios Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 30, 2026
pulisher
Jul 30, 2026

Agios Pharmaceuticals reports $44.7M Q2 product revenue, $100.7M net loss, $964.8M cash - TradingView

Jul 30, 2026
pulisher
Jul 30, 2026

Agios Pharmaceuticals Q2 Loss Narrows as Revenue Increases - marketscreener.com

Jul 30, 2026
pulisher
Jul 29, 2026

Biotechs bring big launches and pharma rivalries into Q2 earnings period - biospace.com

Jul 29, 2026
pulisher
Jul 28, 2026

AGIO|Agios Pharmaceuticals Inc|Price:36.308|Chg%:-0.662 - TradingKey

Jul 28, 2026
pulisher
Jul 28, 2026

Agios Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Jul 28, 2026
pulisher
Jul 28, 2026

Understanding the Setup: (AGIO) and Scalable Risk - Stock Traders Daily

Jul 28, 2026
pulisher
Jul 28, 2026

The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals - Yahoo Finance

Jul 28, 2026
pulisher
Jul 28, 2026

Agios Pharmaceuticals (AGIO) Stock Analysis: Navigating Growth with a 14.62% Potential Upside - DirectorsTalk Interviews

Jul 28, 2026
pulisher
Jul 27, 2026

Agios Pharmaceuticals Inc (AGIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Agios Pharmaceuticals Inc (AGIO) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Agios Pharmaceuticals Inc (AGIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Agios Pharmaceuticals Inc (AGIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Agios Pharmaceuticals Inc (AGIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Agios Pharmaceuticals Inc (AGIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Agios Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:AGIO - TradingView

Jul 25, 2026
pulisher
Jul 24, 2026

Agios Pharmaceuticals Inc. (AGIO) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com

Jul 24, 2026
pulisher
Jul 24, 2026

Knott David M Jr Has $3.15 Million Stake in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Jul 24, 2026

Agios Pharmaceuticals Inc (AGIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$63.32
price down icon 0.52%
$58.60
price up icon 0.07%
$36.20
price down icon 0.22%
$123.74
price down icon 2.05%
$228.65
price up icon 0.67%
ONC ONC
$347.48
price down icon 2.40%
大文字化:     |  ボリューム (24 時間):